Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank93
3Y CAGR-15.7%
5Y CAGR+29.8%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-15.7%/yr
vs +55.0%/yr prior
5Y CAGR
+29.8%/yr
Recent deceleration
Acceleration
-70.7pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
3.7x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $198.69M | +98.7% |
| 2024 | $100.02M | +0.1% |
| 2023 | $99.92M | -69.9% |
| 2022 | $331.55M | +814.1% |
| 2021 | $36.27M | -32.8% |
| 2020 | $54.00M | +15.6% |
| 2019 | $46.70M | -18.6% |
| 2018 | $57.38M | -61.4% |
| 2017 | $148.63M | +267.0% |
| 2016 | $40.50M | - |